Getting Breast Cancer Drugs Right to the Source Breast cancers most often arise in the cells that line the breast ducts, so breast cancer researchers developed an intraductal therapy in which anticancer drugs are administered via a tiny catheter inserted through the nipple into the breast ducts.
Not exact matches
When you
get to
cancers like
breast, prostate and kidney, which have smaller numbers of mutations, the
drugs aren't quite as effective.
The chief aim of I - SPY 2, according to Esserman and others, is to collapse the time it takes to
get a green or red light for a potential new
breast cancer drug from 10 years to 1 year.
And so you saw things like cases like a woman coming in with
breast cancer and there was no oncologist, there are no treatment infusion rooms where you can put central lines in and give the chemotherapy, but they could
get the chemotherapies on the gray market — that's where there are pirated versions of the key
drugs that you need — in India.
But while insurers stand to save plenty of money if less women
got lymphedema after
breast cancer, unlike when new
cancer drugs hit the market, exercise offers no immediate profit prospects for pharmaceutical or biotechnology companies — and no multi-million dollar advertising campaign advising patients to query their doctors about it.
â $ There are two
drugs approved for reducing your risk of
getting breast cancer: raloxifene, which is approved for use in postmenopausal women, and tamoxifen, which is approved for all ages, â $ explains Dr. Gralow.
(ISTOCKPHOTO) There's no such thing as
breast cancer prevention (although prophylactic mastectomy or taking
drugs to prevent a recurrence
get pretty close).